Movement Alert|Corcept Therapeutics Falls 4.25% in Regular Trading, Q3 Beat Overshadowed by Unchanged Full-Year Outlook

Market Focus
Nov 17

On November 17, Corcept Therapeutics fell 4.25% in Regular Trading, trading at $69.825 per share, with turnover of $13.8923 million.

The move appears tied to lingering caution after the company reported third-quarter results above expectations but only reiterated full-year revenue guidance, limiting incremental upside for sentiment.

Corcept Therapeutics previously reported Q3 EPS of $1.01, up from $0.16 a year earlier and above consensus estimates of $0.79 to $0.81, while revenue rose to $340.5 million from $207.6 million and also topped forecasts near $336 million. However, the company maintained its full-year revenue outlook at $1.1 billion to $1.2 billion, broadly in line with expectations around $1.15 billion, rather than raising guidance after a strong quarter. Shares had already fallen in after-hours trading following the release, suggesting the earnings beat was largely offset by a lack of stronger forward guidance.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10